BMC Medical Genomics

Table 1 The relationships between CDH11 expression and the clinical variables of OSCC

From: Expression signature and molecular basis of CDH11 in OSCC detected by a combination of multiple methods

Clinical variables			CDH11
Clinical variables			Positive	Negative	P value
Gender		Male	27 16	23 17	0.623
Gender		Female	27 16	23 17	0.623
Age		≤ 60	9 34	13 27	0.233
Age		>60	9 34	13 27	0.233
Smoking		Yes No	23 20	22 18	0.890
Alcohol history		Yes No	28 15	24 16	0.630
Lymph node metastasis		N0	6 23 14	17 14 9	Vs N1: 0.007^* Vs N2: 0.920 Vs N0: 0.017^*
		N1
		N2
T stage	T1-2		13 30	20 20	0.066
T stage	T3-4		13 30	20 20	0.066
Tumor Differentiation	High		32	26	Vs Medium: 0.168
	Medium		4	8	Vs Low: 0.302
	Low		7	6	Vs High: 0.931
PNI		+	20 23	9 31	0.022^*
PNI		-	20 23	9 31	0.022^*
KI67		+ -	16 27	14 26	0.834

Note: PNI: perineural infiltration; *: P < 0.05

Back to article page

ISSN: 1755-8794

Contact us

Submission enquiries: bmcmedicalgenomics@biomedcentral.com
General enquiries: ORSupport@springernature.com